Table 2: Fatty acid plasma percentage distribution in study subjects.

Systematic nameCommon nameShort designationCasesControls
MinMaxMinMax33th centilea67th centilea

SFAsb
 HexadecanoicPalmitic(16  :  0) 27.70 42.75 26.3542.7535.1036.92
 HeptadecanoicMargaric (daturic)(17 : 0) 0.19 3.20 0.01 4.970.520.64
 OctadecanoicStearic(18 : 0) 11.84 22.41 8.52 21.8916.5318.10
 EicosanoicArachidic(20 : 0) 0.01 1.11 0.01 1.260.320.47
 TetracosanoicLignoceric(24 : 0) 0.01 2.25 0.01 1.650.721.11
MUFAsb
 cis-9-octadecenoicOleic (18 : 1n-9) 9.5241.69 8.2138.4712.7214.88
 cis-15-tetracosenoicNervonic(24 : 1n-9) 0.01 4.02 0.01 3.521.041.62
PUFAsb
 9,12-octadecadienoicLinoleic(18 : 2n-6) 11.3423.5611.3223.5417.1920.07
 5,8,11,14-eicosatetraenoicArachidonic(20 : 4n-6) 0.28 7.411.08 6.772.753.77
 5,8,11,14,17-eicosapentaenoicEPA(20 : 5n-3) 0.01 1.44 0.01 2.350.140.33
 7,10,13,16,19-docosapentaenoicDPA(22 : 5n-3) 0.01 0.60 0.01 0.750.090.18
 4,7,10,13,16,19-docosahexaenoicDHA(22 : 6n-3) 0.18 2.06 0.01 1.950.430.66

MeanStandard deviationMeanStandard deviation33th centilea66th centilea

Groupings
 SFAs55.953.5955.684.1254.5756.72
 MUFAs + PUFAs39.293.8639.374.1838.3440.73
 MUFAs16.275.0216.224.9914.3116.52
 PUFAs23.024.5923.153.6021.5825.06
 SFAs/MUFAs + PUFAs1.440.211.440.261.351.48
 SFAs/PUFAs2.540.582.470.47 2.232.61
 n-3 PUFAs1.100.601.060.69 0.71 1.11
 n-6 PUFAs21.924.3322.093.4020.5324.04
 n-3 PUFAs/n-6 PUFAs0.050.020.050.030.030.05

aPercentile cutpoints based on fatty acid distribution in controls.
bSFAs: saturated fatty acids; MUFAs: monounsaturated fatty acids; PUFAs: polyunsaturated fatty acids.